Form 4: Boston Scientific EVP Wendy Carruthers Executes Stock Options Under 10b5-1 Plan
SEC Form 4 Filing
Wendy Carruthers, EVP of Human Resources at Boston Scientific, executed stock options and sold shares under a pre-established Rule 10b5-1 trading plan.
Summary
- Wendy Carruthers, EVP of Human Resources at Boston Scientific, filed a Form 4 detailing changes in beneficial ownership.
- On November 1, 2024, Carruthers exercised stock options to acquire 3,066 shares at $17.26 and 1,197 shares at $24.55.
- Also on November 1, 2024, Carruthers sold 6,983 shares of common stock at $84.33.
- These transactions were executed under a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.
- Following these transactions, Carruthers directly owns 32,028 shares of common stock and derivative securities including 3,066 stock options exercisable at $17.26 and 14,380 stock options exercisable at $24.55.
Sentiment
Score: 6
Explanation: Neutral sentiment as the transactions are part of a pre-planned trading strategy and do not necessarily reflect a change in the executive's confidence in the company.
Positives
- The transactions were executed under a pre-established 10b5-1 trading plan, which is generally viewed as a transparent and compliant practice.
Risks
- Executive stock sales can sometimes be perceived negatively by investors, although the use of a 10b5-1 plan mitigates this concern.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. The use of a 10b5-1 plan is a standard practice to avoid insider trading concerns.
Comparison to Industry Standards
- Executive compensation practices, including stock options and trading plans, are common across the medical device industry.
- Companies like Medtronic and Abbott also utilize similar mechanisms for executive compensation and stock transactions.
- The vesting schedules and exercise prices of the options are within typical ranges for executive compensation packages in comparable companies.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares in the open market.
Key Dates
| Date | Description |
|---|---|
| 02/22/2017 | First anniversary of grant date for stock options vesting in four equal annual installments. |
| 02/28/2018 | First anniversary of grant date for stock options vesting in four equal annual installments. |
| 11/17/2023 | Date of adoption of the Rule 10b5-1 trading plan. |
| 11/01/2024 | Date of stock option exercise and sale of shares. |
| 02/22/2026 | Expiration date for some stock options. |
| 02/28/2027 | Expiration date for some stock options. |
| 11/04/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.